trpa1 antibody Search Results


94
Alomone Labs anti trpa1 rabbit monoclonal antibody
Anti Trpa1 Rabbit Monoclonal Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti trpa1 rabbit monoclonal antibody/product/Alomone Labs
Average 94 stars, based on 1 article reviews
anti trpa1 rabbit monoclonal antibody - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

89
Novus Biologicals anti trpa1 antibody
Anti Trpa1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 89/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti trpa1 antibody/product/Novus Biologicals
Average 89 stars, based on 1 article reviews
anti trpa1 antibody - by Bioz Stars, 2026-04
89/100 stars
  Buy from Supplier

93
Novus Biologicals trpa1
Trpa1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trpa1/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
trpa1 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

95
Novus Biologicals antibodies against trpa1
A Representative confocal image of a coronal of the NAc obtained from <t>Trpa1</t> -shRNA-injected mice. Scale bar: 500 μm. ac, anterior commissure. B Validation of TRPA1 KD in the NAc of Trpa1 -shRNA-injected mice by Western blotting (n = 10). C Representative heat maps of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD cocaine CPP tests in male mice. CPP score of each group in the TRPA1 KD cocaine CPP tests in male mice (n = 10). D CPP score of each group in the TRPA1 antagonist (A-967079) cocaine CPP tests in male mice [n = 10 (control), 10 (cocaine), 10 (A-967079 5 mg/kg, cocaine), 10 (A-967079 15 mg/kg, cocaine), 11 (A-967079 50 mg/kg, cocaine), and 10 (A-967079 50 mg/kg)]. E Representative heat maps of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD cocaine CPP tests in female mice. CPP score of each group in the TRPA1 KD cocaine CPP tests in female mice (n = 7). F CPP score of each group in the A-967079 cocaine CPP tests in female mice [n = 7 (control), 7 (cocaine), 8 (A-967079 5 mg/kg, cocaine), 8 (A-967079 15 mg/kg, cocaine), 8 (A-967079 50 mg/kg, cocaine), and 8 (A-967079 50 mg/kg)]. G CPP score of each group in the TRPA1 antagonist (HC-030031) cocaine CPP tests in male mice [n = 10 (control), 9 (cocaine), 8 (HC-030031 5 mg/kg, cocaine), 10 (HC-030031 15 mg/kg, cocaine), 9 (HC-030031 50 mg/kg, cocaine), and 6 (HC-030031 50 mg/kg)]. H CPP score of each group in the intra-NAc injection of A-967079 during cocaine CPP tests in male mice [n = 6 (control), 6 (cocaine), and 5 (A-967079, cocaine)]. I CPP score of each group in the intra-VTA injection of A-967079 during cocaine CPP tests in male mice [n = 4 (control), 5 (cocaine), and 5 (A-967079, cocaine)]. Data are presented as mean ± standard error of the mean. * P < 0.05, ** P < 0.01, and *** P < 0.001 versus control; # P < 0.05 versus cocaine; sal, saline; coc, cocaine; Scrambled or Scr, scrambled control; TRPA1 KD or KD, TRPA1 knockdown; HC, HC-030031; A-9, A-967079.
Antibodies Against Trpa1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against trpa1/product/Novus Biologicals
Average 95 stars, based on 1 article reviews
antibodies against trpa1 - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

94
Novus Biologicals anti trpa1
A Representative confocal image of a coronal of the NAc obtained from <t>Trpa1</t> -shRNA-injected mice. Scale bar: 500 μm. ac, anterior commissure. B Validation of TRPA1 KD in the NAc of Trpa1 -shRNA-injected mice by Western blotting (n = 10). C Representative heat maps of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD cocaine CPP tests in male mice. CPP score of each group in the TRPA1 KD cocaine CPP tests in male mice (n = 10). D CPP score of each group in the TRPA1 antagonist (A-967079) cocaine CPP tests in male mice [n = 10 (control), 10 (cocaine), 10 (A-967079 5 mg/kg, cocaine), 10 (A-967079 15 mg/kg, cocaine), 11 (A-967079 50 mg/kg, cocaine), and 10 (A-967079 50 mg/kg)]. E Representative heat maps of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD cocaine CPP tests in female mice. CPP score of each group in the TRPA1 KD cocaine CPP tests in female mice (n = 7). F CPP score of each group in the A-967079 cocaine CPP tests in female mice [n = 7 (control), 7 (cocaine), 8 (A-967079 5 mg/kg, cocaine), 8 (A-967079 15 mg/kg, cocaine), 8 (A-967079 50 mg/kg, cocaine), and 8 (A-967079 50 mg/kg)]. G CPP score of each group in the TRPA1 antagonist (HC-030031) cocaine CPP tests in male mice [n = 10 (control), 9 (cocaine), 8 (HC-030031 5 mg/kg, cocaine), 10 (HC-030031 15 mg/kg, cocaine), 9 (HC-030031 50 mg/kg, cocaine), and 6 (HC-030031 50 mg/kg)]. H CPP score of each group in the intra-NAc injection of A-967079 during cocaine CPP tests in male mice [n = 6 (control), 6 (cocaine), and 5 (A-967079, cocaine)]. I CPP score of each group in the intra-VTA injection of A-967079 during cocaine CPP tests in male mice [n = 4 (control), 5 (cocaine), and 5 (A-967079, cocaine)]. Data are presented as mean ± standard error of the mean. * P < 0.05, ** P < 0.01, and *** P < 0.001 versus control; # P < 0.05 versus cocaine; sal, saline; coc, cocaine; Scrambled or Scr, scrambled control; TRPA1 KD or KD, TRPA1 knockdown; HC, HC-030031; A-9, A-967079.
Anti Trpa1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti trpa1/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
anti trpa1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

95
Novus Biologicals antibodies for anti trpa1
Figure 3. Involvement of reactive oxygen species (ROS) in mechanical pain hypersensitivity following maternal separation (MS). (a, b) Mechanical head-withdrawal threshold in the whisker pad skin following intraperitoneal (a) or subcutaneous (b) administration of the ROS scavenger N-tert-butyl-α-phenylnitrone (PBN) in non-MS and MS rats at 7 weeks (n = 6–7 in each group). *P < 0.05, **P < 0.01, Mann–Whitney U test. (c) Expression of transient receptor potential ankyrin 1 <t>(TRPA1)</t> in the whisker pad skin in the non-MS and MS rats at 7 weeks. Red arrows denote TRPA1-immunoreactivity. Scale bars indicate 30 µm. (d) Immunoblot for TRPA1 in the whisker pad skin at 7 weeks in the non-MS and MS rats (n = 6–7). P = 0.77, unpaired t test. (e) Mechanical head-withdrawal threshold in the whisker pad skin 30 min after intraperitoneal administration of the TRPA1 channel antagonist HC-030031 (HC) to non-MS and MS rats at 7 weeks (n = 5–6 in each group). **P < 0.01, Mann–Whitney U test.
Antibodies For Anti Trpa1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies for anti trpa1/product/Novus Biologicals
Average 95 stars, based on 1 article reviews
antibodies for anti trpa1 - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

93
Aviva Systems anti trpa1
Figure 3. Involvement of reactive oxygen species (ROS) in mechanical pain hypersensitivity following maternal separation (MS). (a, b) Mechanical head-withdrawal threshold in the whisker pad skin following intraperitoneal (a) or subcutaneous (b) administration of the ROS scavenger N-tert-butyl-α-phenylnitrone (PBN) in non-MS and MS rats at 7 weeks (n = 6–7 in each group). *P < 0.05, **P < 0.01, Mann–Whitney U test. (c) Expression of transient receptor potential ankyrin 1 <t>(TRPA1)</t> in the whisker pad skin in the non-MS and MS rats at 7 weeks. Red arrows denote TRPA1-immunoreactivity. Scale bars indicate 30 µm. (d) Immunoblot for TRPA1 in the whisker pad skin at 7 weeks in the non-MS and MS rats (n = 6–7). P = 0.77, unpaired t test. (e) Mechanical head-withdrawal threshold in the whisker pad skin 30 min after intraperitoneal administration of the TRPA1 channel antagonist HC-030031 (HC) to non-MS and MS rats at 7 weeks (n = 5–6 in each group). **P < 0.01, Mann–Whitney U test.
Anti Trpa1, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti trpa1/product/Aviva Systems
Average 93 stars, based on 1 article reviews
anti trpa1 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

92
Novus Biologicals rabbit polyclonal nti trpa1 antibody
Figure 3. Involvement of reactive oxygen species (ROS) in mechanical pain hypersensitivity following maternal separation (MS). (a, b) Mechanical head-withdrawal threshold in the whisker pad skin following intraperitoneal (a) or subcutaneous (b) administration of the ROS scavenger N-tert-butyl-α-phenylnitrone (PBN) in non-MS and MS rats at 7 weeks (n = 6–7 in each group). *P < 0.05, **P < 0.01, Mann–Whitney U test. (c) Expression of transient receptor potential ankyrin 1 <t>(TRPA1)</t> in the whisker pad skin in the non-MS and MS rats at 7 weeks. Red arrows denote TRPA1-immunoreactivity. Scale bars indicate 30 µm. (d) Immunoblot for TRPA1 in the whisker pad skin at 7 weeks in the non-MS and MS rats (n = 6–7). P = 0.77, unpaired t test. (e) Mechanical head-withdrawal threshold in the whisker pad skin 30 min after intraperitoneal administration of the TRPA1 channel antagonist HC-030031 (HC) to non-MS and MS rats at 7 weeks (n = 5–6 in each group). **P < 0.01, Mann–Whitney U test.
Rabbit Polyclonal Nti Trpa1 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal nti trpa1 antibody/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
rabbit polyclonal nti trpa1 antibody - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
Proteintech trpa1 polyclonal antibody
Figure 3. Involvement of reactive oxygen species (ROS) in mechanical pain hypersensitivity following maternal separation (MS). (a, b) Mechanical head-withdrawal threshold in the whisker pad skin following intraperitoneal (a) or subcutaneous (b) administration of the ROS scavenger N-tert-butyl-α-phenylnitrone (PBN) in non-MS and MS rats at 7 weeks (n = 6–7 in each group). *P < 0.05, **P < 0.01, Mann–Whitney U test. (c) Expression of transient receptor potential ankyrin 1 <t>(TRPA1)</t> in the whisker pad skin in the non-MS and MS rats at 7 weeks. Red arrows denote TRPA1-immunoreactivity. Scale bars indicate 30 µm. (d) Immunoblot for TRPA1 in the whisker pad skin at 7 weeks in the non-MS and MS rats (n = 6–7). P = 0.77, unpaired t test. (e) Mechanical head-withdrawal threshold in the whisker pad skin 30 min after intraperitoneal administration of the TRPA1 channel antagonist HC-030031 (HC) to non-MS and MS rats at 7 weeks (n = 5–6 in each group). **P < 0.01, Mann–Whitney U test.
Trpa1 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/trpa1 polyclonal antibody/product/Proteintech
Average 93 stars, based on 1 article reviews
trpa1 polyclonal antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

93
Novus Biologicals alexa
Figure 3. Involvement of reactive oxygen species (ROS) in mechanical pain hypersensitivity following maternal separation (MS). (a, b) Mechanical head-withdrawal threshold in the whisker pad skin following intraperitoneal (a) or subcutaneous (b) administration of the ROS scavenger N-tert-butyl-α-phenylnitrone (PBN) in non-MS and MS rats at 7 weeks (n = 6–7 in each group). *P < 0.05, **P < 0.01, Mann–Whitney U test. (c) Expression of transient receptor potential ankyrin 1 <t>(TRPA1)</t> in the whisker pad skin in the non-MS and MS rats at 7 weeks. Red arrows denote TRPA1-immunoreactivity. Scale bars indicate 30 µm. (d) Immunoblot for TRPA1 in the whisker pad skin at 7 weeks in the non-MS and MS rats (n = 6–7). P = 0.77, unpaired t test. (e) Mechanical head-withdrawal threshold in the whisker pad skin 30 min after intraperitoneal administration of the TRPA1 channel antagonist HC-030031 (HC) to non-MS and MS rats at 7 weeks (n = 5–6 in each group). **P < 0.01, Mann–Whitney U test.
Alexa, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alexa/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
alexa - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


A Representative confocal image of a coronal of the NAc obtained from Trpa1 -shRNA-injected mice. Scale bar: 500 μm. ac, anterior commissure. B Validation of TRPA1 KD in the NAc of Trpa1 -shRNA-injected mice by Western blotting (n = 10). C Representative heat maps of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD cocaine CPP tests in male mice. CPP score of each group in the TRPA1 KD cocaine CPP tests in male mice (n = 10). D CPP score of each group in the TRPA1 antagonist (A-967079) cocaine CPP tests in male mice [n = 10 (control), 10 (cocaine), 10 (A-967079 5 mg/kg, cocaine), 10 (A-967079 15 mg/kg, cocaine), 11 (A-967079 50 mg/kg, cocaine), and 10 (A-967079 50 mg/kg)]. E Representative heat maps of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD cocaine CPP tests in female mice. CPP score of each group in the TRPA1 KD cocaine CPP tests in female mice (n = 7). F CPP score of each group in the A-967079 cocaine CPP tests in female mice [n = 7 (control), 7 (cocaine), 8 (A-967079 5 mg/kg, cocaine), 8 (A-967079 15 mg/kg, cocaine), 8 (A-967079 50 mg/kg, cocaine), and 8 (A-967079 50 mg/kg)]. G CPP score of each group in the TRPA1 antagonist (HC-030031) cocaine CPP tests in male mice [n = 10 (control), 9 (cocaine), 8 (HC-030031 5 mg/kg, cocaine), 10 (HC-030031 15 mg/kg, cocaine), 9 (HC-030031 50 mg/kg, cocaine), and 6 (HC-030031 50 mg/kg)]. H CPP score of each group in the intra-NAc injection of A-967079 during cocaine CPP tests in male mice [n = 6 (control), 6 (cocaine), and 5 (A-967079, cocaine)]. I CPP score of each group in the intra-VTA injection of A-967079 during cocaine CPP tests in male mice [n = 4 (control), 5 (cocaine), and 5 (A-967079, cocaine)]. Data are presented as mean ± standard error of the mean. * P < 0.05, ** P < 0.01, and *** P < 0.001 versus control; # P < 0.05 versus cocaine; sal, saline; coc, cocaine; Scrambled or Scr, scrambled control; TRPA1 KD or KD, TRPA1 knockdown; HC, HC-030031; A-9, A-967079.

Journal: Molecular Psychiatry

Article Title: The ion channel TRPA1 is a modulator of the cocaine reward circuit in the nucleus accumbens

doi: 10.1038/s41380-024-02623-4

Figure Lengend Snippet: A Representative confocal image of a coronal of the NAc obtained from Trpa1 -shRNA-injected mice. Scale bar: 500 μm. ac, anterior commissure. B Validation of TRPA1 KD in the NAc of Trpa1 -shRNA-injected mice by Western blotting (n = 10). C Representative heat maps of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD cocaine CPP tests in male mice. CPP score of each group in the TRPA1 KD cocaine CPP tests in male mice (n = 10). D CPP score of each group in the TRPA1 antagonist (A-967079) cocaine CPP tests in male mice [n = 10 (control), 10 (cocaine), 10 (A-967079 5 mg/kg, cocaine), 10 (A-967079 15 mg/kg, cocaine), 11 (A-967079 50 mg/kg, cocaine), and 10 (A-967079 50 mg/kg)]. E Representative heat maps of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD cocaine CPP tests in female mice. CPP score of each group in the TRPA1 KD cocaine CPP tests in female mice (n = 7). F CPP score of each group in the A-967079 cocaine CPP tests in female mice [n = 7 (control), 7 (cocaine), 8 (A-967079 5 mg/kg, cocaine), 8 (A-967079 15 mg/kg, cocaine), 8 (A-967079 50 mg/kg, cocaine), and 8 (A-967079 50 mg/kg)]. G CPP score of each group in the TRPA1 antagonist (HC-030031) cocaine CPP tests in male mice [n = 10 (control), 9 (cocaine), 8 (HC-030031 5 mg/kg, cocaine), 10 (HC-030031 15 mg/kg, cocaine), 9 (HC-030031 50 mg/kg, cocaine), and 6 (HC-030031 50 mg/kg)]. H CPP score of each group in the intra-NAc injection of A-967079 during cocaine CPP tests in male mice [n = 6 (control), 6 (cocaine), and 5 (A-967079, cocaine)]. I CPP score of each group in the intra-VTA injection of A-967079 during cocaine CPP tests in male mice [n = 4 (control), 5 (cocaine), and 5 (A-967079, cocaine)]. Data are presented as mean ± standard error of the mean. * P < 0.05, ** P < 0.01, and *** P < 0.001 versus control; # P < 0.05 versus cocaine; sal, saline; coc, cocaine; Scrambled or Scr, scrambled control; TRPA1 KD or KD, TRPA1 knockdown; HC, HC-030031; A-9, A-967079.

Article Snippet: The membranes were then immunoblotted with primary antibodies against TRPA1 (rabbit, Novus, NB110-40763, 1:1000), DAT (rabbit, Millipore, AB2231, 1:3000), p-DAT (rabbit, Abcam, ab183486, 1:1000), TH (rabbit, Abcam, ab112, 1:5000), GluA1 (rabbit, Abcam, ab31232, 1:1000), GluA2 (rabbit, Abcam, ab20673, 1:1000) and ß-actin (mouse, Santa Cruz, Dallas, TX, USA, SC-47778, 1:2000) overnight at 4 °C.

Techniques: shRNA, Injection, Biomarker Discovery, Western Blot, Control, Saline, Knockdown

A Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from the NAc core of male mice. B Left, sEPSC amplitude in NAc core MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 16 (scrambled, saline), 13 (scrambled, cocaine), 9 (KD, saline), and 15 (KD, cocaine)]. Right, sEPSC frequency in NAc core MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 16 (scrambled, saline), 13 (scrambled, cocaine), 9 (KD, saline), and 15 (KD, cocaine)]. C Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from the NAc shell of male mice. D Left, sEPSC amplitude in NAc shell MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 8 (scrambled, saline), 10 (scrambled, cocaine), 11 (KD, saline), and 11 (KD, cocaine)]. Right, sEPSC frequency in NAc shell MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 8 (scrambled, saline), 10 (scrambled, cocaine), 11 (KD, saline), and 11 (KD, cocaine)]. E Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from the NAc core of female mice. F Left, sEPSC amplitude in NAc core MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 10 (scrambled, saline), 9 (scrambled, cocaine), 9 (KD, saline), and 9 (KD, cocaine)]. Right, sEPSC frequency in NAc core MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 10 (scrambled, saline), 9 (scrambled, cocaine), 9 (KD, saline), and 9 (KD, cocaine)]. G Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from the NAc shell of female mice. H Left, sEPSC amplitude in NAc shell MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 8 (scrambled, saline), 10 (scrambled, cocaine), 10 (KD, saline), and 8 (KD, cocaine)]. Right, sEPSC frequency in NAc shell MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 8 (scrambled, saline), 10 (scrambled, cocaine), 10 (KD, saline), and 8 (KD, cocaine)]. I Representative images of Western blot from each protein assayed. J Relative GluA1 protein expression in the NAc of the scrambled control and TRPA1 KD groups following cocaine CPP tests in male mice (n = 8). K Relative GluA2 protein expression in the NAc of the scrambled control and TRPA1 KD groups following cocaine CPP tests in male mice (n = 8). L Relative TRPA1 protein expression in the NAc of the scrambled control and TRPA1 KD groups following cocaine CPP tests in male mice [n = 8 (scrambled) and 9 (KD)]. Data are presented as mean ± standard error of the mean. * P < 0.05, ** P < 0.01 and *** P < 0.001; S or sal Saline, C or coc cocaine, Scr Scrambled control, KD TRPA1 knockdown.

Journal: Molecular Psychiatry

Article Title: The ion channel TRPA1 is a modulator of the cocaine reward circuit in the nucleus accumbens

doi: 10.1038/s41380-024-02623-4

Figure Lengend Snippet: A Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from the NAc core of male mice. B Left, sEPSC amplitude in NAc core MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 16 (scrambled, saline), 13 (scrambled, cocaine), 9 (KD, saline), and 15 (KD, cocaine)]. Right, sEPSC frequency in NAc core MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 16 (scrambled, saline), 13 (scrambled, cocaine), 9 (KD, saline), and 15 (KD, cocaine)]. C Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from the NAc shell of male mice. D Left, sEPSC amplitude in NAc shell MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 8 (scrambled, saline), 10 (scrambled, cocaine), 11 (KD, saline), and 11 (KD, cocaine)]. Right, sEPSC frequency in NAc shell MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 8 (scrambled, saline), 10 (scrambled, cocaine), 11 (KD, saline), and 11 (KD, cocaine)]. E Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from the NAc core of female mice. F Left, sEPSC amplitude in NAc core MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 10 (scrambled, saline), 9 (scrambled, cocaine), 9 (KD, saline), and 9 (KD, cocaine)]. Right, sEPSC frequency in NAc core MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 10 (scrambled, saline), 9 (scrambled, cocaine), 9 (KD, saline), and 9 (KD, cocaine)]. G Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from the NAc shell of female mice. H Left, sEPSC amplitude in NAc shell MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 8 (scrambled, saline), 10 (scrambled, cocaine), 10 (KD, saline), and 8 (KD, cocaine)]. Right, sEPSC frequency in NAc shell MSNs of saline- and cocaine-injected scrambled control and TRPA1 KD groups [n = 8 (scrambled, saline), 10 (scrambled, cocaine), 10 (KD, saline), and 8 (KD, cocaine)]. I Representative images of Western blot from each protein assayed. J Relative GluA1 protein expression in the NAc of the scrambled control and TRPA1 KD groups following cocaine CPP tests in male mice (n = 8). K Relative GluA2 protein expression in the NAc of the scrambled control and TRPA1 KD groups following cocaine CPP tests in male mice (n = 8). L Relative TRPA1 protein expression in the NAc of the scrambled control and TRPA1 KD groups following cocaine CPP tests in male mice [n = 8 (scrambled) and 9 (KD)]. Data are presented as mean ± standard error of the mean. * P < 0.05, ** P < 0.01 and *** P < 0.001; S or sal Saline, C or coc cocaine, Scr Scrambled control, KD TRPA1 knockdown.

Article Snippet: The membranes were then immunoblotted with primary antibodies against TRPA1 (rabbit, Novus, NB110-40763, 1:1000), DAT (rabbit, Millipore, AB2231, 1:3000), p-DAT (rabbit, Abcam, ab183486, 1:1000), TH (rabbit, Abcam, ab112, 1:5000), GluA1 (rabbit, Abcam, ab31232, 1:1000), GluA2 (rabbit, Abcam, ab20673, 1:1000) and ß-actin (mouse, Santa Cruz, Dallas, TX, USA, SC-47778, 1:2000) overnight at 4 °C.

Techniques: Saline, Injection, Control, Western Blot, Expressing, Knockdown

A Timeline of TRPA1 antagonist cocaine self-administration acquisition test on a fixed-ratio 2 (FR2) schedule. B Mean number of infusions from 3 days before test sessions and 2 days of FR2 test sessions following injection of a TRPA1 antagonist (A-967079) or vehicle in a cocaine self-administration test (n = 6). Active lever presses from 2 days of FR2 tests (n = 6). Inactive lever presses from 2 days of FR2 tests (n = 6). Cocaine intake from 1 day before test sessions and 2 days of tests (n = 6). C Rate of response to sucrose pellets from 1 day before the test sessions and 2 days of test sessions following injection of A-967079 or vehicle in a sucrose reinforcement test (n = 5). D Timeline of TRPA1 antagonist cocaine self-administration test on a progressive ratio (PR) and reinstatement (RI) schedule. E Mean number of infusions from 3 days before PR test sessions (n = 5) and breakpoint during the PR test following injection of A-967079 or vehicle in a cocaine self-administration test (n = 5). F Mean number of infusions from 12 days of extinction sessions (n = 8). G Numbers of infusions (n = 4), active lever presses (n = 4) and inactive lever presses (n = 4) during cocaine-induced reinstatement following injection of A-967079 or vehicle. Data are presented as mean ± standard error of the mean. * P < 0.05 and ** P < 0.01 versus control; Veh vehicle, A-9 A-967079.

Journal: Molecular Psychiatry

Article Title: The ion channel TRPA1 is a modulator of the cocaine reward circuit in the nucleus accumbens

doi: 10.1038/s41380-024-02623-4

Figure Lengend Snippet: A Timeline of TRPA1 antagonist cocaine self-administration acquisition test on a fixed-ratio 2 (FR2) schedule. B Mean number of infusions from 3 days before test sessions and 2 days of FR2 test sessions following injection of a TRPA1 antagonist (A-967079) or vehicle in a cocaine self-administration test (n = 6). Active lever presses from 2 days of FR2 tests (n = 6). Inactive lever presses from 2 days of FR2 tests (n = 6). Cocaine intake from 1 day before test sessions and 2 days of tests (n = 6). C Rate of response to sucrose pellets from 1 day before the test sessions and 2 days of test sessions following injection of A-967079 or vehicle in a sucrose reinforcement test (n = 5). D Timeline of TRPA1 antagonist cocaine self-administration test on a progressive ratio (PR) and reinstatement (RI) schedule. E Mean number of infusions from 3 days before PR test sessions (n = 5) and breakpoint during the PR test following injection of A-967079 or vehicle in a cocaine self-administration test (n = 5). F Mean number of infusions from 12 days of extinction sessions (n = 8). G Numbers of infusions (n = 4), active lever presses (n = 4) and inactive lever presses (n = 4) during cocaine-induced reinstatement following injection of A-967079 or vehicle. Data are presented as mean ± standard error of the mean. * P < 0.05 and ** P < 0.01 versus control; Veh vehicle, A-9 A-967079.

Article Snippet: The membranes were then immunoblotted with primary antibodies against TRPA1 (rabbit, Novus, NB110-40763, 1:1000), DAT (rabbit, Millipore, AB2231, 1:3000), p-DAT (rabbit, Abcam, ab183486, 1:1000), TH (rabbit, Abcam, ab112, 1:5000), GluA1 (rabbit, Abcam, ab31232, 1:1000), GluA2 (rabbit, Abcam, ab20673, 1:1000) and ß-actin (mouse, Santa Cruz, Dallas, TX, USA, SC-47778, 1:2000) overnight at 4 °C.

Techniques: Injection, Control

A Timeline of cocaine and TRPA1 antagonist (HC-030031) application and current recording in FSCV. Representative dopamine voltammetry traces in the NAc core during FSCV. B Relative dopamine area under the curve (AUC) in the NAc core of cocaine responses following treatment with HC-030031 or vehicle [n = 7 (control), 5 (cocaine), 8 (HC-030031, cocaine), and 8 (HC-030031)]. C Dopamine peak in the NAc core of mice with cocaine responses following treatment with HC-030031 or vehicle [n = 7 (control), 5 (cocaine), 8 (HC-030031, cocaine), and 8 (HC-030031)]. D Relative ratio of human dopamine transporter (hDAT) uptake efficacy in hDAT and mouse TRPA1 (mTRPA1) stably transfected HEK293 cells following treatment with cocaine and TRPA1 agonist (AITC) (n = 3). E Relative ratio of hDAT uptake efficacy in hDAT and mTRPA1 stably transfected HEK293 cells following treatment with cocaine and TRPA1 antagonist (A-967079) (n = 3). F Timeline of cocaine and A-967079 injections, with the NAc dissected 1 day after the last dose. Representative images of Western blot from each protein assayed. G Relative DAT protein expression in the NAc of cocaine- and A-967079-injected groups (n = 9). H Relative ratio of p-DAT to total DAT protein expression in the NAc of cocaine- and A-967079-injected groups (n = 9). I Relative TH protein expression in the NAc of cocaine- and A-967079-injected groups (n = 9). Data are presented as mean ± standard error of the mean. * P < 0.05 and *** P < 0.001 versus control; # P < 0.05, ## P < 0.01, and ### P < 0.001 versus cocaine; sal saline, coc cocaine, Veh vehicle, HC HC-030031.

Journal: Molecular Psychiatry

Article Title: The ion channel TRPA1 is a modulator of the cocaine reward circuit in the nucleus accumbens

doi: 10.1038/s41380-024-02623-4

Figure Lengend Snippet: A Timeline of cocaine and TRPA1 antagonist (HC-030031) application and current recording in FSCV. Representative dopamine voltammetry traces in the NAc core during FSCV. B Relative dopamine area under the curve (AUC) in the NAc core of cocaine responses following treatment with HC-030031 or vehicle [n = 7 (control), 5 (cocaine), 8 (HC-030031, cocaine), and 8 (HC-030031)]. C Dopamine peak in the NAc core of mice with cocaine responses following treatment with HC-030031 or vehicle [n = 7 (control), 5 (cocaine), 8 (HC-030031, cocaine), and 8 (HC-030031)]. D Relative ratio of human dopamine transporter (hDAT) uptake efficacy in hDAT and mouse TRPA1 (mTRPA1) stably transfected HEK293 cells following treatment with cocaine and TRPA1 agonist (AITC) (n = 3). E Relative ratio of hDAT uptake efficacy in hDAT and mTRPA1 stably transfected HEK293 cells following treatment with cocaine and TRPA1 antagonist (A-967079) (n = 3). F Timeline of cocaine and A-967079 injections, with the NAc dissected 1 day after the last dose. Representative images of Western blot from each protein assayed. G Relative DAT protein expression in the NAc of cocaine- and A-967079-injected groups (n = 9). H Relative ratio of p-DAT to total DAT protein expression in the NAc of cocaine- and A-967079-injected groups (n = 9). I Relative TH protein expression in the NAc of cocaine- and A-967079-injected groups (n = 9). Data are presented as mean ± standard error of the mean. * P < 0.05 and *** P < 0.001 versus control; # P < 0.05, ## P < 0.01, and ### P < 0.001 versus cocaine; sal saline, coc cocaine, Veh vehicle, HC HC-030031.

Article Snippet: The membranes were then immunoblotted with primary antibodies against TRPA1 (rabbit, Novus, NB110-40763, 1:1000), DAT (rabbit, Millipore, AB2231, 1:3000), p-DAT (rabbit, Abcam, ab183486, 1:1000), TH (rabbit, Abcam, ab112, 1:5000), GluA1 (rabbit, Abcam, ab31232, 1:1000), GluA2 (rabbit, Abcam, ab20673, 1:1000) and ß-actin (mouse, Santa Cruz, Dallas, TX, USA, SC-47778, 1:2000) overnight at 4 °C.

Techniques: Control, Stable Transfection, Transfection, Western Blot, Expressing, Injection, Saline

A Representative dot plots and histograms from flow cytometry present the surface expression of TRPA1 of D1R- and D2R- cells in the striatum (n = 3). Bar graphs presented as median defined as the normalized mean fluorescence intensity (MFI) of TRPA1 [n = 3 (WT mice for D1R-MSNs) and 3 (WT mice for D2R-MSNs)]. B Representative images of RNAscope showing the distributions of Trpa1 (red), Drd1 (yellow), Drd2 (green), and DAPI (blue) in the NAc. Scale bar: 20 μm. C Quantification of the fluorescence of TRPA1 mRNA puncta signals in the NAc subregions of saline- or cocaine-injected mice (n = 4). D Quantification of the percentage of D1R- or D2R-MSNs co-localized with TRPA1 signal (n = 4). E Quantification of the Drd1 - or Drd2 -positive cells (n = 4). Data are presented as mean ± standard error of the mean. sal Saline, coc cocaine.

Journal: Molecular Psychiatry

Article Title: The ion channel TRPA1 is a modulator of the cocaine reward circuit in the nucleus accumbens

doi: 10.1038/s41380-024-02623-4

Figure Lengend Snippet: A Representative dot plots and histograms from flow cytometry present the surface expression of TRPA1 of D1R- and D2R- cells in the striatum (n = 3). Bar graphs presented as median defined as the normalized mean fluorescence intensity (MFI) of TRPA1 [n = 3 (WT mice for D1R-MSNs) and 3 (WT mice for D2R-MSNs)]. B Representative images of RNAscope showing the distributions of Trpa1 (red), Drd1 (yellow), Drd2 (green), and DAPI (blue) in the NAc. Scale bar: 20 μm. C Quantification of the fluorescence of TRPA1 mRNA puncta signals in the NAc subregions of saline- or cocaine-injected mice (n = 4). D Quantification of the percentage of D1R- or D2R-MSNs co-localized with TRPA1 signal (n = 4). E Quantification of the Drd1 - or Drd2 -positive cells (n = 4). Data are presented as mean ± standard error of the mean. sal Saline, coc cocaine.

Article Snippet: The membranes were then immunoblotted with primary antibodies against TRPA1 (rabbit, Novus, NB110-40763, 1:1000), DAT (rabbit, Millipore, AB2231, 1:3000), p-DAT (rabbit, Abcam, ab183486, 1:1000), TH (rabbit, Abcam, ab112, 1:5000), GluA1 (rabbit, Abcam, ab31232, 1:1000), GluA2 (rabbit, Abcam, ab20673, 1:1000) and ß-actin (mouse, Santa Cruz, Dallas, TX, USA, SC-47778, 1:2000) overnight at 4 °C.

Techniques: Flow Cytometry, Expressing, Fluorescence, RNAscope, Saline, Injection

A Representative confocal image of a coronal slice of the NAc obtained from AAV-DIO-hChR2-EYFP-injected D1-Cre mice. Scale bar: 500 μm. ac, anterior commissure. B Timeline of TRPA1 KD CPP tests with optogenetic activation of D1R MSNs. Schematic representation of the cocaine/blue laser-paired conditioning paradigm. C Representative heat map images of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD optogenetic cocaine (5 mg/kg, sub-threshold dose) CPP tests. D CPP score of each group in the TRPA1 KD optogenetic cocaine (5 mg/kg, sub-threshold dose) CPP tests (n = 7). E CPP score of each group in the TRPA1 KD optogenetic saline CPP tests [n = 5 (control), 6 (scrambled, stimulation), and 6 (TRPA1 KD, stimulation)]. F Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from D1R-MSNs in the NAc core. G Amplitude and frequency of sEPSCs in NAc D1R-MSNs of scrambled control and TRPA1 KD animals by saline and cocaine [n = 8 (D1R-MSNs, scrambled, saline), 6 (D1R-MSNs, scrambled, cocaine), 8 (D1R-MSNs, TRPA1 KD, saline), and 11 (D1R-MSNs, TRPA1 KD, cocaine)]. H Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from nonD1R-MSNs in the NAc core. I Amplitude and frequency of nonD1R-MSNs of scrambled control and TRPA1 KD animals by saline and cocaine [n = 12 (nonD1R-MSNs, scrambled, saline), 8 (nonD1R-MSNs, scrambled, cocaine), 8 (nonD1R-MSNs, TRPA1 KD, saline), and 9 (nonD1R-MSNs, TRPA1 KD, cocaine)]. Data are presented as mean ± standard error of the mean. * P < 0.05 and ** P < 0.01 versus control; ## P < 0.01 versus Scr light, sal saline, coc cocaine, Scr Scrambled control, TRPA1 KD or KD TRPA1 knockdown, w week.

Journal: Molecular Psychiatry

Article Title: The ion channel TRPA1 is a modulator of the cocaine reward circuit in the nucleus accumbens

doi: 10.1038/s41380-024-02623-4

Figure Lengend Snippet: A Representative confocal image of a coronal slice of the NAc obtained from AAV-DIO-hChR2-EYFP-injected D1-Cre mice. Scale bar: 500 μm. ac, anterior commissure. B Timeline of TRPA1 KD CPP tests with optogenetic activation of D1R MSNs. Schematic representation of the cocaine/blue laser-paired conditioning paradigm. C Representative heat map images of time spent in each CPP chamber during pre-test and post-test periods of the TRPA1 KD optogenetic cocaine (5 mg/kg, sub-threshold dose) CPP tests. D CPP score of each group in the TRPA1 KD optogenetic cocaine (5 mg/kg, sub-threshold dose) CPP tests (n = 7). E CPP score of each group in the TRPA1 KD optogenetic saline CPP tests [n = 5 (control), 6 (scrambled, stimulation), and 6 (TRPA1 KD, stimulation)]. F Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from D1R-MSNs in the NAc core. G Amplitude and frequency of sEPSCs in NAc D1R-MSNs of scrambled control and TRPA1 KD animals by saline and cocaine [n = 8 (D1R-MSNs, scrambled, saline), 6 (D1R-MSNs, scrambled, cocaine), 8 (D1R-MSNs, TRPA1 KD, saline), and 11 (D1R-MSNs, TRPA1 KD, cocaine)]. H Representative raw traces of spontaneous excitatory post-synaptic current (sEPSC) recordings from nonD1R-MSNs in the NAc core. I Amplitude and frequency of nonD1R-MSNs of scrambled control and TRPA1 KD animals by saline and cocaine [n = 12 (nonD1R-MSNs, scrambled, saline), 8 (nonD1R-MSNs, scrambled, cocaine), 8 (nonD1R-MSNs, TRPA1 KD, saline), and 9 (nonD1R-MSNs, TRPA1 KD, cocaine)]. Data are presented as mean ± standard error of the mean. * P < 0.05 and ** P < 0.01 versus control; ## P < 0.01 versus Scr light, sal saline, coc cocaine, Scr Scrambled control, TRPA1 KD or KD TRPA1 knockdown, w week.

Article Snippet: The membranes were then immunoblotted with primary antibodies against TRPA1 (rabbit, Novus, NB110-40763, 1:1000), DAT (rabbit, Millipore, AB2231, 1:3000), p-DAT (rabbit, Abcam, ab183486, 1:1000), TH (rabbit, Abcam, ab112, 1:5000), GluA1 (rabbit, Abcam, ab31232, 1:1000), GluA2 (rabbit, Abcam, ab20673, 1:1000) and ß-actin (mouse, Santa Cruz, Dallas, TX, USA, SC-47778, 1:2000) overnight at 4 °C.

Techniques: Injection, Activation Assay, Saline, Control, Knockdown

Figure 3. Involvement of reactive oxygen species (ROS) in mechanical pain hypersensitivity following maternal separation (MS). (a, b) Mechanical head-withdrawal threshold in the whisker pad skin following intraperitoneal (a) or subcutaneous (b) administration of the ROS scavenger N-tert-butyl-α-phenylnitrone (PBN) in non-MS and MS rats at 7 weeks (n = 6–7 in each group). *P < 0.05, **P < 0.01, Mann–Whitney U test. (c) Expression of transient receptor potential ankyrin 1 (TRPA1) in the whisker pad skin in the non-MS and MS rats at 7 weeks. Red arrows denote TRPA1-immunoreactivity. Scale bars indicate 30 µm. (d) Immunoblot for TRPA1 in the whisker pad skin at 7 weeks in the non-MS and MS rats (n = 6–7). P = 0.77, unpaired t test. (e) Mechanical head-withdrawal threshold in the whisker pad skin 30 min after intraperitoneal administration of the TRPA1 channel antagonist HC-030031 (HC) to non-MS and MS rats at 7 weeks (n = 5–6 in each group). **P < 0.01, Mann–Whitney U test.

Journal: Scientific reports

Article Title: Involvement of oxidative stress in orofacial mechanical pain hypersensitivity following neonatal maternal separation in rats.

doi: 10.1038/s41598-023-50116-1

Figure Lengend Snippet: Figure 3. Involvement of reactive oxygen species (ROS) in mechanical pain hypersensitivity following maternal separation (MS). (a, b) Mechanical head-withdrawal threshold in the whisker pad skin following intraperitoneal (a) or subcutaneous (b) administration of the ROS scavenger N-tert-butyl-α-phenylnitrone (PBN) in non-MS and MS rats at 7 weeks (n = 6–7 in each group). *P < 0.05, **P < 0.01, Mann–Whitney U test. (c) Expression of transient receptor potential ankyrin 1 (TRPA1) in the whisker pad skin in the non-MS and MS rats at 7 weeks. Red arrows denote TRPA1-immunoreactivity. Scale bars indicate 30 µm. (d) Immunoblot for TRPA1 in the whisker pad skin at 7 weeks in the non-MS and MS rats (n = 6–7). P = 0.77, unpaired t test. (e) Mechanical head-withdrawal threshold in the whisker pad skin 30 min after intraperitoneal administration of the TRPA1 channel antagonist HC-030031 (HC) to non-MS and MS rats at 7 weeks (n = 5–6 in each group). **P < 0.01, Mann–Whitney U test.

Article Snippet: Membranes were blocked with TBST (0.2% Tween-20 diluted in Tris-buffered saline) containing 5% Blocking-One (Nacalai Tesque, Kyoto, Japan) for 1 h at room temperature and then incubated overnight at 4 °C with primary antibodies for anti-TRPA1 (rabbit, Polyclonal, 1:500; NB110-40763, Novus Biologicals, LLC, Centennial, CO, USA), and anti-β-actin antibody (mouse monoclonal, 1:200; sc-69879; Santa Cruz, San Diego, CA, USA).

Techniques: Whisker Assay, MANN-WHITNEY, Expressing, Western Blot